Cargando…

The neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis

Detalles Bibliográficos
Autores principales:	Chung, Jin-Young, Sunwoo, Jun-Sang, Kim, Min-Wook, Kim, Manho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Highlights
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590220/ https://www.ncbi.nlm.nih.gov/pubmed/26487835 http://dx.doi.org/10.4103/1673-5374.162690

Ejemplares similares

Is hyperexcitability really guilty in amyotrophic lateral sclerosis?
por: Leroy, Felix, et al.
Publicado: (2015)

The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis
por: Tanaka, Hirotaka, et al.
Publicado: (2012)

Repetitive Nerve Stimulation Test in Amyotrophic Lateral Sclerosis with Predominant Oropharyngeal Manifestations
por: Kim, Jee Young, et al.
Publicado: (2011)

Mechanisms of Neuroprotection by Protein Disulphide Isomerase in Amyotrophic Lateral Sclerosis
por: Walker, Adam K., et al.
Publicado: (2011)

Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
por: Oh, Ki‐Wook, et al.
Publicado: (2018)

Impaired Perception of Emotional Expression in Amyotrophic Lateral Sclerosis
por: Oh, Seong-il, et al.
Publicado: (2016)

Abnormal Oculomotor Functions in Amyotrophic Lateral Sclerosis
por: Kang, Bong-Hui, et al.
Publicado: (2018)

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018)

Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
por: Muzio, Luca, et al.
Publicado: (2020)

Neuroprotective effects of violacein in a model of inherited amyotrophic lateral sclerosis
por: Olivera-Bravo, Silvia, et al.
Publicado: (2022)

Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury
por: Shin, Samuel S., et al.
Publicado: (2015)

Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
por: Cha, Sun Joo, et al.
Publicado: (2022)

Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems
por: Herrando-Grabulosa, Mireia, et al.
Publicado: (2016)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis
por: Kim, Sung-Min, et al.
Publicado: (2017)

Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis
por: Jeon, Yu-Mi, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Neuroprotection and recovery from early-life adversity: considerations for environmental enrichment
por: Kentner, Amanda C.
Publicado: (2015)

Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis
por: Gyawali, Asmita, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
por: Corcia, Philippe, et al.
Publicado: (2012)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants
por: Sung, Wonjae, et al.
Publicado: (2022)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis
por: Gong, Zhenxiang, et al.
Publicado: (2022)

Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis
por: Oh, Seong-il, et al.
Publicado: (2015)

Usefulness of diffusion tensor imaging findings as biomarkers for amyotrophic lateral sclerosis
por: Baek, Seol-Hee, et al.
Publicado: (2020)

An analysis of variants in TARDBP in the Korean population with amyotrophic lateral sclerosis: comparison with previous data
por: Sung, Wonjae, et al.
Publicado: (2023)

The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neurons
por: Chung, Jin-Young, et al.
Publicado: (2015)

Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis
por: Guo, Wenting, et al.
Publicado: (2017)

Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis
por: Ravnik-Glavač, Metka, et al.
Publicado: (2020)

Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis
por: Barbo, Maruša, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
por: Park, Jin-Mo, et al.
Publicado: (2019)

Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis
por: Li, Jin‐Yue, et al.
Publicado: (2022)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_opco29pllj0hqo6uckliem5a3d